The carboxyl-terminal domain of the heavy chain of tetanus toxin prevents dopaminergic degeneration and improves motor behavior in rats with striatal MPP+-lesions

Neuroscience Research

Volumn 65, Issue 1, 2009, Pages 98-106

  Mendieta, Liliana ^a   Venegas, Berenice ^a   Moreno, Natalia ^b   Patricio, Aleidy ^a   Martínez, Isabel ^a   Aguilera, José ^b   Limón, Ilhuicamina Daniel ^a  

^a BENEMÉRITA UNIVERSIDAD AUTÓNOMA DE PUEBLA   (Mexico)

^b INSTITUT DE NEUROCIÈNCIES   (Spain)

Author keywords

Dopamine; Fine motor skills; Motor asymmetry; Neuroprotection; Striatum

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 3 O METHYLDOPAMINE; 3,4 DIHYDROXYPHENYLACETIC ACID; HOMOVANILLIC ACID; TETANUS TOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINERGIC SYSTEM; DRUG EFFICACY; MALE; MOTOR PERFORMANCE; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; SURVIVAL RATE;

EID: 67650502218     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2009.06.001     Document Type: Article

References (45)

1. Abrous D.N., Shaltot A.R.A., Torres E.M., and Dunnet S.B. Dopamine-rich grafts in the neostriatum and/or nucleus accumbens: effects on drug-induced behaviours and skilled paw-reaching. Neuroscience 43 1 (1993) 187-193
2. +, induces damage of striatal cell nuclei in Sprague-Dawley rats. J. Chem. Neuroanat. 32 (2006) 90-100
3. Caleo, M., Schiavo, G., 2009. Central effects of tetanus and botulinum neurotoxins. Toxicon, doi:10.1016/j.toxicon.2008.12.026.
4. Carlton E., Teng Q., Federici T., Yang J., Riley J., and Boulis N.M. Fusion of the tetanus toxin C fragment binding domain and Bcl-xL for protection of peripheral nerve neurons. Neurosurgery 63 6 (2008) 1175-1184
5. Chaïb-Oukadour I., Gil C., and Aguilera J. The C-terminal domain of the heavy chain of tetanus toxin rescues cerebellar granule neurons from apoptotic death: involvement of phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways. J. Neurochem. 90 5 (2004) 1227-1236
6. Chaïb-Oukadour I., Gil C., Rodríguez-Alvarez J., Ortega A., and Aguilera J. Tetanus toxin HC fragment reduces neuronal MPP+ toxicity. Mol. Cell. Neurosci. 41 (2009) 297-303
7. Chaturvedi T.N., Fabrini C., Juncos J.L., and Mouradian M.M. Motor response complications with chronic levodopa therapy. Adv. Neurol. 53 (2006) 377-381
8. Chen X., Liu W., Guoyuan Y., Liu Z., Smith S., Calne D.B., and Chen S. Protective effects of intracerebral adenoviral-mediated GDNF gene transfer in a rat model of Parkinson's disease. Parkinsonism Relat. Disord. 10 1 (2003) 1-7
9. Cohen A.D., Tillerson J.L., Smith A.D., Schallert T., and Zigmond M.J. Neuroprotective effects of prior limb use in 6-hydroxydopamine-treated rats: possible role of GDNF. J. Neurochem. 85 (2003) 299-305
10. Emborg M.E. Evaluation of animal models of Parkinson's disease for neuroprotective strategies. J. Neurosci. Methods 139 (2004) 121-143
11. Emsley P., Fotinou C., Black I., Fairweather N.F., Charles I.G., Watts C., Hewitt E., and Isaacs N.W. The structures of the H(C) fragment of tetanus toxin with carbohydrate subunit complexes provide insight into ganglioside binding. J. Biol. Chem. 275 (2000) 8889-8894
12. Francis J.W., Bastia E., Matthews C.C., Parks D.A., Scwarzschild M.A., Brown R.H., and Fishman P.S. Tetanus toxin fragment C a vector to enhance delivery of protein to the CNS. Brain Res. 1011 (2004) 7-13
13. Galan-Rodriguez B., del-Marco A., Flores J.A., Ramiro-Fuentes S., Gonzalez-Aparicio R., Tunez I., Tasset I., and Fernandez-Espejo E. Grafts of extra-adrenal chromaffin cells as aggregates show better survival rate and regenerative effects on parkinsonian rats than dispersed cell grafts. Neurobiol. Dis. 29 3 (2008) 529-542
14. Galvan A., Floran B., Erlij D., and Aceves J. Intrapallidal dopamine restores motor deficits induced by 6-hydroxydopamine in the rat. J. Neural. Transm. 108 2 (2001) 153-166
15. Ghorayeb I., Fernagut P.O., Hervier L., Labattu B., Bioulac B., and Tison F. A 'single toxin-double lesion' rat model of striatonigral degeneration by intrastriatal 1-methyl-4-phenylpyridinium ion injection: a motor behavioural analysis. Neuroscience 115 2 (2002) 533-546
16. Gil C., Chaib-oukadour I., and Aguilera J. C-terminal fragment of tetanus toxin heavy chain activates Akt and MEK/ERK signaling pathways in a Trk receptor-dependent manner in cultured cortical neurons. J. Neurochem. 373 (2003) 613-620
17. Gil C., Chaib-Oukadour I., Blasi J., and Aguilera J. HC fragment (C-terminal portion of the heavy chain) of tetanus toxin activates protein kinase C isoforms and phosphoproteins involved in signal transduction. J. Biochem. 356 1 (2001) 97-103
18. Gil C., Pelliccioni P., Itarte E., and Aguilera J. Differential action of nerve growth factor and phorbol ester TPA on rat synaptosomal PKC isoenzymes. Neurochem. Int. 35 4 (1999) 281-291
19. Heikkila R.E., Manzino L., Cabbat F.S., and Duvoisin R.C. Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by monoamine oxidase inhibitors. Nature 311 (1984) 467-469
20. Heikkila R.E., Nicklas W.J., Vyas I., and Duvoisin R.C. Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity. Neurosci. Lett. 62 3 (1985) 389-394
21. Herreros J., Lalli G., and Schiavo G. C-terminal half of tetanus toxin fragment C is sufficient for neuronal binding and interaction with a putative protein receptor. Biochem. J. 347 (2000) 199-204
22. Kearns C.M., and Gash D.M. GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo. Brain Res. 672 (1995) 104-111
23. Kirik D., Georgievska B., and Björklund A. Localized striatal delivery of GDNF as a treatment for Parkinson disease. Nat. Neurosci. 7 2 (2004) 105-110
24. Kirik D., Geprgoevsla B., Rosenblad C., and Björklund A. Delayed infusion of GDNF promotes recovery of motor function in the partial lesion model of Parkinson's disease. Euro. J. Neurosci. 13 (2001) 1589-1599
25. Klein A., Metz G.A., Papazoglou A., and Nikkhah G. Differential effects on forelimb grasping behavior induced by fetal dopaminergic grafts in hemiparkinsonian rats. Neurobiol. Dis. 27 (2007) 24-35
26. Lalli G., and Schiavo G. Analysis of retrograde transport in motor neurons reveals common endocytic carriers for tetanus toxin and neurotrophin receptor p75 NTR. J. Cell Biol. 156 (2002) 233-239
27. Lin L.F., Doherly D.H., Lile J.D., Bektesh S., and Collins F. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260 (1993) 1130-1132
28. Lundblad M., Andersson M., Winkler C., Kirik D., Wierup N., and Cenci M.A. Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease. Euro. J. Neurosci. 15 1 (2002) 120-132
29. Marín C., Rodriguez-Oroz M.C., and Obeso J.A. Motor complications in Parkinson's disease and the clinical significance of rotational behavior in the rat: have we wasted our time?. Exp. Neurol. 197 (2006) 269-274
30. Mizuno Y., Saitoh T., and Sone N. Inhibition of mitochondrial NADH-ubiquinone oxidoreductase activity by 1-methyl-4-phenylpyridinium ion. Biochem. Biophys. Res. Commun. 143 (1987) 294-309
31. Montoya C.P., Campbell-Hope L.J., Pemberton K.D., and Dunnet S.B. The "staircase test": a measure of independent forelimb reaching and grasping abilities in rats. J. Neurosci. Methods 36 (1991) 219-228
32. Obeso J.A., Rodríguez-Oroz M.C., Rodríguez M., Arbizu J., and Giménez-Amaya J.M. The basal ganglia and disorders of movement: pathophysiological mechanisms. News Physiol. Sci. 17 (2002) 51-55
33. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates. 4th edition (1998), Academic Press, London, UK
34. Przedborski S., and Vila M. The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model, a tool to explore the pathogenesis of Parkinson's disease. Ann. N.Y. Acad. Sci. 991 (2003) 189-198
35. Schallert T., Fleming S.M., Leasure J.L., Tillerson J.L., and Bland S.T. CNS platicity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology 39 (2000) 777-787
36. Schallert T., and Tillerson J.L. Intervention strategies for degeneration of dopamine neurons in parkinsonism: optimizing behavioral assessment of outcome. In: Emerich D.F., Dean R.L., and Sangerg P.R. (Eds). Central Nervous System Diseases (1999), Humana Press Inc., Totowa, NJ 131-151
37. Schneider J.S., and Peacock V. Differential effects of GDNF treatment on rotational asymmetry, skilled forelimb use deficits and sensory neglect in unilateral 6-OHDA-lesioned rats. Restorative Neurol. Neurosci. 13 (1998) 205-212
38. + or rotenone display differential sensitivity to amphetamine and apomorphine. Pharm. Biochem. Behav. 84 (2006) 321-329
39. + into the nigrostriatal dopamine pathway-I. Behavioural, neurochemical and histological characterization of the lesion. Neuroscience 27 1 (1988) 117-128
40. Sonsalla P.K., Zeevalk G.D., Manzino L., Giovanni A., and Nicklas W.J. MK-801 fails to protect against the dopaminergic neuropathology produced by systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice or nigral 1-methyl-4-phenylpyridinium in rats. J. Neurochem. 58 (1992) 1979-1982
41. +) nigral toxicity in the rat by prior decortication or MK-801 treatment: a stereological estimate of neuronal loss. Neurobiol. Aging 14 (1993) 295-301
42. Tomac A., Widenfalk J., Lin L.F., Kohno T., Ebendal T., Hoffer B.J., and Olsson L. Retrograde axonal transport of glial cell line-derived neurotrophic factor in the adult nigrostriatal system suggest a trophic role in the adult. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 8274-8278
43. Ungerstedt U., and Arbuthnott G.W. Quantitative recording of rotational behavior in rats after 6-hydroxydopamine lesions of the nigrostriatal dopamine system. Brain Res. 24 (1970) 485-493
44. Whishaw I.Q., and Pellis S.M. The structure of skilled forelimb reaching in the rat: a proximally driven movement with a single distal rotatory component. Behav. Brain Res. 41 1 (1990) 49-59
45. Wider C., Burkhard P.R., Sajadi A., and Vingerhoets F.J. Neuronal death and growth factors: new therapeutic approaches in Parkinson's disease. Rev. Med. Suisse. 2 3 (64) (2006) 1158-1162